1. Short-term efficacy of high intensity group and individual education in patients with type 2 diabetes: a randomized single-center trial
- Author
-
Lucia Frittitta, Andrea Tumminia, Roberto Baratta, N. La Spina, L. Romeo, L. Tomaselli, R. Reale, and Giuseppa Padova
- Subjects
Blood Glucose ,Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Type 2 diabetes ,Single Center ,Diabetes Therapy ,law.invention ,Body Mass Index ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Randomized controlled trial ,Patient Education as Topic ,law ,Diabetes mellitus ,Internal medicine ,Surveys and Questionnaires ,medicine ,Humans ,Glycemic ,Glycated Hemoglobin ,business.industry ,Middle Aged ,medicine.disease ,Prognosis ,Self Care ,Self-Help Groups ,Diabetes Mellitus, Type 2 ,Glycemic Index ,030220 oncology & carcinogenesis ,Cohort ,Quality of Life ,Female ,business ,Body mass index ,Follow-Up Studies - Abstract
The aim of this randomized study was to examine the efficacy of two high intensity educational programs: the conversation maps-based (CM™) education and the individual education (IE), compared to usual care (UC) in a cohort of type 2 diabetic (T2DM) patients. Ninety T2DM outpatients (30 per group) were randomized and 79 finished the study and were analyzed. The CM™ and IE groups received four educational sessions at 0, 4, 8 and 12 weeks, while the UC group received two brief individual sessions at 0 and 12 weeks. We evaluated glycemic control (HbA1c), diabetes treatment, body mass index (BMI) and carried out a questionnaire survey at three time points (before intervention, at 12 and at 32 weeks) to assess patients’ satisfaction, attitudes toward diabetes and dietary knowledge. All the three groups showed a significant and comparable reduction of both HbA1c and BMI. Diabetes therapy needed to be reinforced in a higher percentage of cases (39.3%) among UC patients compared to the IE (14.8%; p = 0.04) and the CM™ (8.3%; p = 0.01) groups. At 32 weeks Diabetes Treatment Satisfaction (DTSQ Q1 + Q4–8) significantly improved in the CM™ group (25.8 ± 4.5 vs. 22.4 ± 6.0; p
- Published
- 2018